FindTrial
Sign In

Urodynamic Evaluation and Clinical Efficacy of Sacral Nerve Magnetic Stimulation Combined with Back-Shu and Front-Mu Acupoint Acupuncture in Patients with Neurogenic Bladder After Spinal Cord Injury

Study on the Clinical Efficacy of Motor Imagery Therapy Combined with Pelvic Floor Magnetic Stimulation for Neurogenic Bladder after Spinal Cord Injury

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500114112
Enrollment
Unknown
Registered
2025-12-08
Start date
2026-01-01
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurogenic bladder

Interventions

Control group:Conventional rehabilitation therapy
PFMS group:Conventional rehabilitation therapy plus pelvic floor magnetic stimulation
Combined intervention group:The same interventions as PFMS Group with the addition of motor imagery therapy.

Sponsors

Qinghai Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis meets the International Standards for Neurological Classification of Spinal Cord Injury established by the American Spinal Injury Association (ASIA), and is confirmed by spinal imaging (CT or MRI); 2. Clinical diagnosis confirms neurogenic bladder. 3. Age 18-70 years, gender (no restriction) (as of the date of signing the informed consent form); 4. Past the spinal shock phase (presence of sacral reflexes, such as the bulbocavernosus reflex or deep tendon reflexes), with an ASIA Impairment Scale grade of B to D. 5. The patient is in stable condition with stable vital signs, able to cooperate with relevant examinations and tolerate the treatment. 6. No cognitive impairment, able to follow simple instructions. 7. Voluntary participation in this study, with the patient and their family informed and having signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe urinary tract infection or renal impairment. 2. Patients complicated with severe cardiac, hepatic, renal, or other systemic diseases. 3. Patients with poor compliance who are unable to cooperate or complete the treatment cycle. 4. Patients with metal implants in the skull or sacrococcygeal region, or those with a cardiac pacemaker. 5. Patients who are unsuitable for intermittent catheterization. 6. Other factors contribute to the occurrence of NB.

Design outcomes

Primary

MeasureTime frame
Maximum bladder capacity;Maximum flow rate;Intravesical pressure;Post-void residual volume;Neurogenic bladder symptom score, NBSS;—

Countries

China

Contacts

Public ContactZhang Rong

Qinghai Provincial People's Hospital

zrtyj0943@126.com+86 173 0971 2021

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026